Sun Pharma Q4 profit jumps two-fold to Rs 1,713.69 crore

Country's largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth quarter ended March 31, 2016.

The company had posted a net profit of Rs 889.24 crore for the same period of the previous quarter, Sun Pharmaceutical Industries said in a filing to the BSE.

Consolidated total income of the group increased to Rs 7,599.21 crore for the quarter under consideration as against Rs 6,505.04 crore for the corresponding period of 2015.

For the fiscal year ended March 31 the company posted a net profit of Rs 4,715.91 crore. It was Rs 4,539.38 crore for the previous fiscal year.

Consolidated total income of the company stood at Rs 28,728.95 crore for the recently ended fiscal year as against Rs 27,842.84 crore for the year ago fiscal.

Sun Pharma is the world's fifth largest speciality generic pharmaceutical company and India's top pharmaceutical company.

Despite the jump in net profits, the company's shares opened down nearly 3%. At open, Sun Pharma's shares were down 2.77% at Rs 790.65 per share.